Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

Karen Schreiber; Savino Sciascia; Ian N Bruce; Ian Giles; Maria J Cuadrado; Hannah Cohen; Caroline Gordon; David Isenberg; Soren Jacobsen; Saskia Middeldorp; Marta Mosca; Sue Pavord; Massimo Radin; Dario Roccatello; Jane Salmon; Evelyne Vinet; Anne Voss; Linda Watkins; Beverley J Hunt

doi:10.1016/S2665-9913(20)30382-9

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

Karen Schreiber, Savino Sciascia, Ian N Bruce, Ian Giles, Maria J Cuadrado, Hannah Cohen, Caroline Gordon, David Isenberg, Soren Jacobsen, Saskia Middeldorp, Marta Mosca, Sue Pavord, Massimo Radin, Dario Roccatello, Jane Salmon, Evelyne Vinet, Anne Voss, Linda Watkins, Beverley J Hunt

Inflammation and Ageing

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	E735-E6736
Number of pages	2
Journal	The Lancet Rheumatology
Volume	2
Issue number	12
DOIs	https://doi.org/10.1016/S2665-9913(20)30382-9
Publication status	E-pub ahead of print - 29 Oct 2020

Access to Document

10.1016/S2665-9913(20)30382-9

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30382-9/fulltext#articleInformation

Cite this

Schreiber, K., Sciascia, S., Bruce, I. N., Giles, I., Cuadrado, M. J., Cohen, H., Gordon, C., Isenberg, D., Jacobsen, S., Middeldorp, S., Mosca, M., Pavord, S., Radin, M., Roccatello, D., Salmon, J., Vinet, E., Voss, A., Watkins, L., & Hunt, B. J. (2020). Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians. The Lancet Rheumatology, 2(12), E735-E6736. Advance online publication. https://doi.org/10.1016/S2665-9913(20)30382-9

@article{24e64f084382420289c0a249e7fe2aa0,

title = "Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians",

author = "Karen Schreiber and Savino Sciascia and Bruce, {Ian N} and Ian Giles and Cuadrado, {Maria J} and Hannah Cohen and Caroline Gordon and David Isenberg and Soren Jacobsen and Saskia Middeldorp and Marta Mosca and Sue Pavord and Massimo Radin and Dario Roccatello and Jane Salmon and Evelyne Vinet and Anne Voss and Linda Watkins and Hunt, {Beverley J}",

year = "2020",

month = oct,

day = "29",

doi = "10.1016/S2665-9913(20)30382-9",

language = "English",

volume = "2",

pages = "E735--E6736",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Elsevier",

number = "12",

}

Schreiber, K, Sciascia, S, Bruce, IN, Giles, I, Cuadrado, MJ, Cohen, H, Gordon, C, Isenberg, D, Jacobsen, S, Middeldorp, S, Mosca, M, Pavord, S, Radin, M, Roccatello, D, Salmon, J, Vinet, E, Voss, A, Watkins, L & Hunt, BJ 2020, 'Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians', The Lancet Rheumatology, vol. 2, no. 12, pp. E735-E6736. https://doi.org/10.1016/S2665-9913(20)30382-9

TY - JOUR

T1 - Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

AU - Schreiber, Karen

AU - Sciascia, Savino

AU - Bruce, Ian N

AU - Giles, Ian

AU - Cuadrado, Maria J

AU - Cohen, Hannah

AU - Gordon, Caroline

AU - Isenberg, David

AU - Jacobsen, Soren

AU - Middeldorp, Saskia

AU - Mosca, Marta

AU - Pavord, Sue

AU - Radin, Massimo

AU - Roccatello, Dario

AU - Salmon, Jane

AU - Vinet, Evelyne

AU - Voss, Anne

AU - Watkins, Linda

AU - Hunt, Beverley J

PY - 2020/10/29

Y1 - 2020/10/29

U2 - 10.1016/S2665-9913(20)30382-9

DO - 10.1016/S2665-9913(20)30382-9

M3 - Letter

SN - 2665-9913

VL - 2

SP - E735-E6736

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 12

ER -